You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rigosertib sodium

Showing 1 - 25 of 3,058
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recessive Dystrophic Epidermolysis Bullosa Trial in Philadelphia (Rigosertib Sodium, Quality-of-Life Assessment)

Recruiting
  • Recessive Dystrophic Epidermolysis Bullosa
  • Rigosertib Sodium
  • Quality-of-Life Assessment
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Aug 31, 2021

MDS Trial in France, Germany, United States (Oral rigosertib)

Completed
  • Myelodysplastic Syndromes
  • Oral rigosertib
  • Stanford, California
  • +13 more
Jun 15, 2021

Epidermolysis Bullosa Dystrophica, Squamous Cell Carcinoma Trial in Salzburg (Rigosertib Oral Capsules / Rigosertib Intravenous)

Recruiting
  • Epidermolysis Bullosa Dystrophica
  • Squamous Cell Carcinoma
  • Rigosertib Oral Capsules / Rigosertib Intravenous
  • Salzburg, Austria
    EB House Austria/Dept. of Dermatology University Hospital
Nov 3, 2022

MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)

Completed
  • Myelodysplastic Syndromes
  • +3 more
  • rigosertib sodium
  • Stanford, California
  • +34 more
Jun 29, 2020

Myelodysplastic Syndrome Trial in Japan (SyB C-1101)

Completed
  • Myelodysplastic Syndrome
  • SyB C-1101
  • Nagoya, Aichi, Japan
  • +8 more
Nov 14, 2022

Myelodysplastic Syndrome Trial in Japan (SyB C-1101 and Azacytidine)

Withdrawn
  • Myelodysplastic Syndrome
  • SyB C-1101 and Azacytidine
  • Nagoya, Aichi, Japan
  • +3 more
Nov 14, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

Not yet recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 28, 2023

Myelodysplastic Syndrome Trial in Japan (SyB C-1101)

Completed
Has Results
  • Myelodysplastic Syndrome
  • SyB C-1101
  • Nagoya, Aichi, Japan
  • +3 more
Nov 14, 2022

Myelodysplastic Syndrome Trial in Nagoya, Fukuoka, Tokyo (SyB L-1101)

Completed
Has Results
  • Myelodysplastic Syndrome
  • SyB L-1101
  • Nagoya, Aichi, Japan
  • +2 more
Nov 14, 2022

Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or

Terminated
  • Myelodysplastic Syndrome
  • +3 more
  • La Jolla, California
  • +157 more
Sep 22, 2022

NSCLC, Adenocarcinoma, Stage IV Trial in New York (Rigosertib, Nivolumab)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Feb 8, 2022

Plasma Sodium and Sodium Administration in the ICU

Recruiting
  • Hypernatremia
  • +2 more
    • Linköping, Sweden
      University Hospital Linköping
    Sep 15, 2023

    Acute Ischemic Stroke Trial in Shanghai (Sodium valproate, Normal saline)

    Recruiting
    • Acute Ischemic Stroke
    • Sodium valproate
    • Normal saline
    • Shanghai, Shanghai, China
      Renji Hospital, Shanghai Jiao Tong University School of Medicine
    Aug 26, 2023

    SODIUM ACCUMULATION STUDY IN HAEMODIALYSIS: BRAIN STUDY

    Not yet recruiting
    • Dialysis; Complications
      • Derby, United Kingdom
        Centre for Kidney Research and Innovation
      Jul 21, 2023

      Hyperkalemia Trial in Alexandria (sodium zirconium cyclosilicate (SZC), sodium polystyrene sulfonate)

      Not yet recruiting
      • Hyperkalemia
      • sodium zirconium cyclosilicate (SZC)
      • sodium polystyrene sulfonate
      • Alexandria, Egypt
        Faculty of Medicine, Aexandria University
      Sep 7, 2023

      Blood Pressure, Salt; Excess, Diabete Type 2 Trial in Pisa (Hypersodic/Hyposodic diet)

      Recruiting
      • Blood Pressure
      • +2 more
      • Hypersodic/Hyposodic diet
      • Pisa, PI, Italy
        Azienda Ospedaliero-Universitaria Pisana
      Aug 23, 2023

      Dry Eye Disease Trial in Jakarta Pusat (Diquafosol sodium 3%, Sodium hyaluronate 0.1%)

      Recruiting
      • Dry Eye Disease
      • Diquafosol sodium 3%
      • Sodium hyaluronate 0.1%
      • Jakarta Pusat, Jakarta, Indonesia
        RSUPN Dr. Cipto Mangunkusumo
      Nov 24, 2023

      Infectious Diseases Trial in Taichung (cefoperazone sodium and sulbactam sodium)

      Active, not recruiting
      • Infectious Diseases
      • cefoperazone sodium and sulbactam sodium
      • Taichung, Taiwan
        Taichung Veterans General Hospital
      Jan 29, 2023

      Helicobacter Pylori Infection Trial in Chang chun (TNP-2198, Rabeprazole Sodium, Amoxicillin)

      Completed
      • Helicobacter Pylori Infection
      • Chang chun, Jilin, China
        The First Hospital of Jilin University
      Oct 7, 2023

      Idiopathic Pulmonary Fibrosis Trial in Hialeah Gardens (20mM sodium pyruvate nasal spray, Saline Placebo control nasal spray)

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • 20mM sodium pyruvate nasal spray
      • Saline Placebo control nasal spray
      • Hialeah Gardens, Florida
        Family First Medical Research Center
      Sep 16, 2023

      Stroke, Acute Trial in Karachi (Sodium Chloride 0.9% infusion alone or in combination with Sodim acetate with normal saline in a

      Recruiting
      • Stroke, Acute
      • Sodium Chloride 0.9% infusion alone or in combination with Sodim acetate with normal saline in a ratio 1;1, 2;1 and 3;1
      • Karachi, Pakistan
        Aga Khan University
      May 19, 2023

      Stress Ulcer Bleeding Trial in Shanghai, Urumchi (Esomeprazole 40mg, Ilaprazole Sodium, Placebo 1)

      Completed
      • Stress Ulcer Bleeding
      • Esomeprazole 40mg
      • +3 more
      • Shanghai, Shanghai, China
      • +1 more
      Apr 22, 2023

      Anticoagulant Trial (Heparin)

      Not yet recruiting
      • Anticoagulant
      • Heparin
      • (no location specified)
      Mar 15, 2023

      Anticoagulant Trial (Heparin)

      Not yet recruiting
      • Anticoagulant
      • Heparin
      • (no location specified)
      Mar 15, 2023

      Bowel Preparation Trial in Nanjing (OSS, OSS+Linzess, PEG-Interferon Alfa)

      Recruiting
      • Bowel Preparation
      • Nanjing, Jiangsu, China
        A single-center, single-blind, randomized controlled clinical st
      Oct 20, 2023